Search Results

Filter
  • 1-10 of  1,024 results for ""Penicillanic Acid""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Decubitus ulcer infection and bacteremia due to tazobactam/piperacillin-resistant Veillonella parvula .

  • Authors : Sahara S; Department of Pharmacy, Kariya Toyota General Hospital, Kariya, Japan.; Kinoshita T

Subjects: Piperacillin*/Piperacillin*/Piperacillin*/therapeutic use ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/therapeutic use ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/pharmacology

  • Source: Nagoya journal of medical science [Nagoya J Med Sci] 2024 Aug; Vol. 86 (3), pp. 524-530.Publisher: Nagoya University School Of Medicine Country of Publication: Japan NLM ID: 0412011 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

In Vitro Susceptibility of Typhoidal, Nontyphoidal, and Extended-Spectrum-β-Lactamase-Producing Salmonella to Ceftolozane/Tazobactam.

  • Authors : Teng JLL; Department of Microbiology, The University of Hong Konggrid.194645.b, Hong Kong, China.; Chan E

Subjects: Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/pharmacology ; Drug Resistance, Bacterial* ; Penicillanic Acid*

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2022 Jan 18; Vol. 66 (1), pp. e0122421. Date of Electronic Publication: 2021 Oct 18.Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Rapid onset severe thrombocytopenia following reexposure to piperacillin-tazobactam: report of two cases and review of the literature.

  • Authors : Alzahrani M; a Oncology Center , King Khalid University Hospital, King Saud University , Riyadh , Saudi Arabia.; Alrumaih I

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*adverse effects ; Penicillanic Acid/Penicillanic Acid/Penicillanic Acid/*analogs & derivatives ; Thrombocytopenia/Thrombocytopenia/Thrombocytopenia/*etiology

  • Source: Platelets [Platelets] 2018 Sep; Vol. 29 (6), pp. 628-631. Date of Electronic Publication: 2018 Jun 04.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9208117 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Meropenem versus piperacillin/tazobactam with or without immunoglobulin as second-line therapy for febrile neutropenia in pediatric patients.

  • Authors : Kobayashi R; Department of Pediatrics, Sapporo Hokuyu Hospital, Japan. Electronic address: .; Hori D

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*administration & dosage ; Febrile Neutropenia/Febrile Neutropenia/Febrile Neutropenia/*drug therapy ; Immunoglobulins, Intravenous/Immunoglobulins, Intravenous/Immunoglobulins, Intravenous/*administration & dosage

  • Source: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi [J Microbiol Immunol Infect] 2018 Aug; Vol. 51 (4), pp. 473-477. Date of Electronic Publication: Publisher: published by Elsevier for the Taiwan Society of Microbiology Country of Publication: England NLM ID: 100956211 Publication Model: Print-Electronic

Record details

×
Academic Journal

Retrospective evaluation of piperacillin-tazobactam, imipenem-cilastatin and meropenem used on surgical floors at a tertiary care hospital in Saudi Arabia.

  • Authors : Youssif E; King Abdullah International Medical Research Center/King Saud bin Abdul Aziz University for Health Sciences, National Guard Health Affairs, Jeddah, Saudi Arabia. Electronic address: .; Aseeri M

Subjects: Tertiary Care Centers*; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*administration & dosage ; Cilastatin/Cilastatin/Cilastatin/*administration & dosage

  • Source: Journal of infection and public health [J Infect Public Health] 2018 Jul - Aug; Vol. 11 (4), pp. 486-490. Date of Electronic Publication: 2017 Nov 15.Publisher: Elsevier Country of Publication: England NLM ID: 101487384 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-035X

Record details

×
Academic Journal

Platelet Dysfunction and Intracerebral Hemorrhage in a Patient Treated with Empiric Piperacillin-Tazobactam in the Neurocritical Care Unit.

  • Authors : Bower M; School of Medicine, UC Irvine Health, Irvine, California, USA. Electronic address: .; Borders C

Subjects: Empirical Research*; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*adverse effects ; Blood Platelet Disorders/Blood Platelet Disorders/Blood Platelet Disorders/*chemically induced

  • Source: World neurosurgery [World Neurosurg] 2018 Jun; Vol. 114, pp. 204-210. Date of Electronic Publication: 2018 Mar 16.Publisher: Elsevier Country of Publication: United States NLM ID: 101528275 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A gratuitous β-Lactamase inducer uncovers hidden active site dynamics of the Staphylococcus aureus BlaR1 sensor domain.

  • Authors : Frederick TE; Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN, United States of America.; Peng JW

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*pharmacology ; Bacterial Proteins/Bacterial Proteins/Bacterial Proteins/*metabolism ; Metalloendopeptidases/Metalloendopeptidases/Metalloendopeptidases/*metabolism

  • Source: PloS one [PLoS One] 2018 May 17; Vol. 13 (5), pp. e0197241. Date of Electronic Publication: 2018 May 17 (Print Publication: 2018).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Editorial & Opinion

Clinical efficacy and safety of cefepime-tazobactam in hospitalized patients in South India.

  • Authors : Bansal N; a Department of Infectious Diseases , Apollo Hospitals , Chennai , Tamil Nadu , India.; Sukhwani KS

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Cephalosporins/Cephalosporins/Cephalosporins/*adverse effects ; Hospitalization/Hospitalization/Hospitalization/*statistics & numerical data

  • Source: Infectious diseases (London, England) [Infect Dis (Lond)] 2018 May; Vol. 50 (5), pp. 391-394. Date of Electronic Publication: 2017 Nov 30.Publisher: Informa Healthcare Country of Publication: England NLM ID: 101650235 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  1,024 results for ""Penicillanic Acid""